公司資料
Myomo 股價、新聞與催化劑
- 股票代碼:
- MYO
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.61 USD (+3.21%)
收盤價
最後更新: 2026年10月1日
41M USD
市值
股價為何變動
截至 2026年10月1日，MYO 上漲 3.21%，收於 $1.61。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Powered Orthotics Company
Myomo develops wearable robotic orthoses for people with impaired arm and hand function. Its devices are intended to help patients perform daily activities after stroke, nerve injury, and other neuromuscular conditions.
MyoPro Product Family
MyoPro detects weak electrical signals from a user's muscles and translates them into powered movement at the elbow, wrist, or hand. Each orthosis is customized to the patient's anatomy and functional needs.
Neuromuscular Patient Population
The device is used by people with upper-limb weakness resulting from stroke, brachial plexus injury, spinal cord injury, multiple sclerosis, and other conditions. Candidates typically retain enough muscle signal to control the powered brace.
Direct-to-Patient Model
Myomo markets directly to prospective users, conducts remote or in-person screening, and works with clinicians and orthotics professionals to complete evaluation and fitting. Patient advocacy and digital lead generation are important to demand creation.
Reimbursement and Fabrication
Revenue depends on insurance authorization and payment, including Medicare and commercial plans. Centralized fabrication, clinical documentation, and claims support help move qualified patients from evaluation to delivery.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。